Medication info
Dongkwang Pitavastatin Tablets 4 mg (Pitavastatin Calcium)

Dongkwang Pitavastatin Tablets 4 mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›4mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet with a score line
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202100045 · Approved 2021.01.05 · Insurance code 645907120

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Hypercholesterolemia
  • dyslipidemia
View approved original text

This medication effectively lowers total cholesterol, bad LDL cholesterol, apolipoprotein B, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It also helps increase good HDL cholesterol levels, improving cardiovascular health. It is a medication that supports better management of blood lipids in conjunction with dietary therapy. It is used for individuals who need cholesterol control and plays a significant role in lowering cardiovascular risk. Therefore, it is effectively used for the treatment of hypercholesterolemia and dyslipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used by individuals who are allergic to specific components. It should also not be administered to those with active liver disease or persistent unknown causes of liver enzyme elevation. Individuals with severe liver impairment or problems with bile flow, as well as those taking the immunosuppressant cyclosporine, should not take this medication. Patients with myopathy or women who are pregnant, possibly pregnant, or breastfeeding should also avoid using this medication. Additionally, the safety of this medication in children has not been established, and there is no experience with its use. Individuals with lactose intolerance or certain genetic metabolic disorders should not take it either. Patients with impaired kidney function should be cautious when using this medication in conjunction with certain lipid-lowering agents or niacin, as there is a risk of muscle damage and worsening kidney function. Those with liver function issues or excessive alcohol consumption should also use this medication with caution, as it may worsen liver function. Individuals with hypothyroidism or genetic muscle disorders, and the elderly, are at a higher risk of adverse reactions and should be monitored closely. Patients with severe muscle weakness may experience exacerbation of symptoms while using this medication. This medication may cause side effects such as muscle pain, fatigue, abdominal pain, rash, and elevated liver enzymes. If muscle pain or weakness, or elevated muscle damage markers are detected in blood tests, the use of this medication should be immediately discontinued. If symptoms of liver dysfunction, thrombocytopenia, or allergic reactions occur, administration should be stopped and a doctor consulted. Rarely, symptoms of the central nervous system, gastrointestinal symptoms, blood abnormalities, or changes in kidney function may occur. This medication is used for the treatment of hypercholesterolemia, so it is advisable to undergo sufficient testing before administration and to combine it with dietary and exercise therapies. During treatment, regular monitoring of blood lipid levels and liver function tests is necessary, and if it is not effective, administration should be discontinued. Patients with weak liver function should start at a lower dosage, and particular attention should be paid to muscle-related adverse reactions when increasing the dosage. This medication has interactions with certain drugs, so co-administration with cyclosporine, fibrate medications, and niacin should be avoided due to an increased risk of muscle damage and worsening kidney function. When taken with cholestyramine, absorption may be inhibited, so an adequate interval between doses should be maintained. Elderly patients may more easily experience adverse reactions due to decreased body function, so they should be observed closely and dosage adjusted as necessary. Pregnant or breastfeeding women should avoid taking this medication as it can be harmful to the fetus and infant, and if pregnancy is confirmed, administration should be stopped immediately. Safety and efficacy in children have not been established, so it should not be used. This medication should not be divided and should be swallowed whole, and it should be kept out of reach of children. Additionally, it must be stored in its original container to prevent misuse or degradation in quality.

Side effects

Abdominal pain, rash, fatigue, paralysis, itching, elevated γ-GT, increased plasma creatine phosphokinase levels, increased serum ALT, increased serum AST, rhabdomyolysis, myalgia, weakness, elevated myoglobin in blood and urine, acute renal failure, myopathy, liver dysfunction, jaundice, thrombocytopenia, urticaria, erythema, angioedema, elevated bilirubin, increased cholinesterase, elevated ALP, increased LDH, rigidity, drowsiness, insomnia, headache, heaviness in the head, dizziness, thirst, dyspepsia, abdominal distension, constipation, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastric discomfort, diarrhea, granulocytopenia, leukopenia, eosinophilia, leukocytosis, elevated globulin, positive Coombs test, anemia, polyuria, increased BUN, elevated serum creatinine, decreased aldosterone, increased aldosterone, increased adrenocorticotropic hormone, increased cortisol, decreased testosterone, muscle cramps, fatigue, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, hematuria, elevated uric acid levels, increased serum potassium and phosphorus, altered taste, sleep disturbances, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, myasthenia gravis, oculomotor myasthenia, facial edema, arm edema, hypersensitivity, headache, dizziness, skin tingling, insomnia, loss of appetite, hypertension, chest discomfort, weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that protects it from light, and it is best stored at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain its effectiveness and prevent degradation.

Appearance and packaging

Appearance

Yellow round film-coated tablet with a score line

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.